Nath Bio-Genes (India) Limited (NATHBIOGEN) — Capital Reinvestment Ratio
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Capital Reinvestment Ratio of 0.45x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rs175.81 Million) in capital expenditures (Rs79.20 Million). Check Nath Bio-Genes (India) Limited tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Nath Bio-Genes (India) Limited Capital Reinvestment Ratio (2013–2025)
This chart tracks Nath Bio-Genes (India) Limited's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see NATHBIOGEN operating cash flow.
Annual Capital Reinvestment Ratio for Nath Bio-Genes (India) Limited (2013–2025)
Year-by-year Capital Reinvestment Ratio for Nath Bio-Genes (India) Limited from 2013 to 2025. See Nath Bio-Genes (India) Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | Rs175.81 Million | Rs79.20 Million | ▲ +230.0% |
| 2024 | 0.14x | Rs614.80 Million | Rs83.93 Million | ▲ +105.5% |
| 2023 | 0.07x | Rs383.67 Million | Rs25.49 Million | ▼ -94.6% |
| 2022 | 1.23x | Rs170.46 Million | Rs210.17 Million | ▼ -88.2% |
| 2021 | 10.42x | Rs11.13 Million | Rs115.98 Million | ▲ +509.4% |
| 2020 | 1.71x | Rs94.74 Million | Rs162.03 Million | ▲ +38.6% |
| 2017 | 1.23x | Rs33.43 Million | Rs41.26 Million | ▲ +1080.6% |
| 2015 | 0.10x | Rs67.55 Million | Rs7.06 Million | ▼ -45.7% |
| 2014 | 0.19x | Rs150.28 Million | Rs28.95 Million | ▼ -87.2% |
| 2013 | 1.50x | Rs142.11 Million | Rs213.54 Million | — |